Lannett (LCINQ) 8-K Other Events

Exhibit 99.1

LANNETT COMPANY, INC.

NET SALES BY MEDICAL INDICATION

	Three months ended									Twelve months ended
($ in thousands)	September 30, 2018		December 31, 2018		March 31, 2019		June 30, 2019			June 30, 2019
Medical Indication
Analgesic	$	1,829	$	2,547	$	946	$	2,929		$	8,251
Anti-Psychosis	10,889		14,036		20,616		27,912			73,453
Cardiovascular	21,770		25,680		22,783		31,234			101,467
Central Nervous System	14,286		7,373		15,906		21,454			59,019
Endocrinology	53,878		88,477		55,210		(43		)	197,522
Gastrointestinal	17,594		12,943		16,501		16,005			63,043
Infectious Disease	4,480		4,616		4,162		3,692			16,950
Migraine	9,737		12,551		9,846		9,458			41,592
Respiratory/Allergy/Cough/Cold	3,584		3,388		2,549		2,958			12,479
Urinary	1,541		1,596		2,096		1,522			6,755
Other	10,805		12,606		14,247		13,859			51,517
Contract manufacturing revenue	4,661		7,905		7,932		2,861			23,359
Net Sales	$	155,054	$	193,718	$	172,794	$	133,841		$	655,407